8-K filing — MARIMED INC. (MRMD)
Filed: 2026-08-12 AccNo: 0001522767-26-000164 Size: 479 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
MariMed Q2 Adj. EPS $(0.01), Inline, Sales $41.925M Beat $39.800M Estimate
MariMed (OTC:MRMD) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $41.925 million which beat the analyst consensus estimate of $39.800
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 12, 2026, 9:05 PM
- Checked
- Aug 12, 2026, 9:05 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading